Tango Therapeutics (TNGX) Profit After Tax (2020 - 2025)
Historic Profit After Tax for Tango Therapeutics (TNGX) over the last 6 years, with Q3 2025 value amounting to $15.9 million.
- Tango Therapeutics' Profit After Tax rose 15445.88% to $15.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$100.5 million, marking a year-over-year increase of 1854.21%. This contributed to the annual value of -$130.3 million for FY2024, which is 2806.85% down from last year.
- Latest data reveals that Tango Therapeutics reported Profit After Tax of $15.9 million as of Q3 2025, which was up 15445.88% from -$38.9 million recorded in Q2 2025.
- Tango Therapeutics' 5-year Profit After Tax high stood at $15.9 million for Q3 2025, and its period low was -$39.9 million during Q1 2025.
- Over the past 5 years, Tango Therapeutics' median Profit After Tax value was -$25.6 million (recorded in 2024), while the average stood at -$24.3 million.
- Its Profit After Tax has fluctuated over the past 5 years, first crashed by 95180677.97% in 2021, then soared by 15445.88% in 2025.
- Over the past 5 years, Tango Therapeutics' Profit After Tax (Quarter) stood at -$22.0 million in 2021, then crashed by 31.82% to -$29.1 million in 2022, then dropped by 5.86% to -$30.8 million in 2023, then dropped by 22.45% to -$37.7 million in 2024, then soared by 142.17% to $15.9 million in 2025.
- Its Profit After Tax stands at $15.9 million for Q3 2025, versus -$38.9 million for Q2 2025 and -$39.9 million for Q1 2025.